Ketamine is an anesthetic that has been growing in use as an off-label prescription to treat depression. Individuals can access the drug through telehealth appointments and clinics in person. But new reporting from Undark shows that many of these providers face few regulations, and much is still unknown about the drug. Dawn Fallik is an associate professor at the University of Delaware and a freelance medicine and science reporter. She covered this story through a grant from the Pulitzer Center and the University of Delaware and joins us to share more on what ketamine clinics look like in Oregon and around the U.S.
